CN
362-75-4
应用筛选条件
关键词:'362-75-4'
显示 1-30 共 54 条结果 关于 "362-75-4" 范围 技术文档
Product Information Sheet - 11759779001
Procedure
Step
Action
1
2
3
4
5
6
7
3. Appendix
3.1 References
1 Cullen B.R. & Malim M.H.
Data Sheet - E8897
splenocytes from an
immunized mouse. The carboxy-terminal part of
recombinant human ezrin (amino acids 362-585) was
used as the immunogen.1, 2 The isotype is determined
using Sigma ImmunoTypeTM Kit (Product
Data Sheet - V6257
7. Gressens, P., et al., Nature, 362, 155-158 (1993).
8. Alle, J., et al., J. Neurooncology., 3, 197 (1985).
9. De la Fuente, M., et al., Adv. Neuroimmunol, 6, 75-
91 (1996).
10. Ganong, W.F., et
Data Sheet - V1631
7. Gressens, P., et al., Nature, 362, 155-158 (1993).
8. Alle, J., et al., J. Neurooncology., 3, 197 (1985).
9. De la Fuente, M., et al., Adv. Neuroimmunol, 6, 75-
91 (1996).
10. Ganong, W.F.
Letrozole and Related Substances (USP) - Purospher®STAR RP-18 endcapped
100000
Table II: Method Precision
Average 4.96 7.874 474456 2453176
Std. Dev. 0.02 0.023 362 3895
% RSD 0.40 0.29 0.08 0.16
Retention Time (min) Area
900000
uV
Injection RS A Letrozole
Anti-Tau-1, clone PC1C6 - Data Sheet
Yoshimura, T., et al., Cell (2005) 120:137-149.
17. Stagi, M., et al., J. Neuroscience (2005) 25:352-362.
18. Cheng, L., et al., J. Neuroscience (2005) 25:395-403.
19. Kishi, M., et al., Science (2005)
DataSheet - D4527
Proc. Natl. Acad.
Sci. USA, 71(12), 4742-4746 (1974).
34. Kunitz, M., J. Gen. Physiol., 33(4), 349-362
(1950).
Notice
We provide information and advice to our customers
on application technologies
Data Sheet - CLLS1009
, MMAC1, at chromosome
10q23.3 that is mutated in multiple advanced
cancers. Nat. Genet., 15(4), 356-362 (1997).
2. Chew, E.C., and Tarnawski, A.S., PTEN regulatory
functions in tumor suppression
XP725 Antibody Number-Lot Number 071M4826
B C D
a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8
Data Sheet - CLLS1004
, MMAC1, at chromosome
10q23.3 that is mutated in multiple advanced
cancers. Nat. Genet., 15(4), 356-362 (1997).
2. Chew, E.C., and Tarnawski, A.S., PTEN regulatory
functions in tumor suppression
Specific Detection of Pseudomonas aeruginosa in Water
trademark of American Type Culture Collection.
Lit. No. AN1024EN00 Rev.– Printed in U.S.A. 11/06 06-362
© 2006 Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.
To Place an Order
Anti-NeuN, clone A60 - Data Sheet
et al., Neuroscience Letters (2004) 362:83-86.
62) Demeter, K., et al., Experimental Neurology (2004) 188:254-267.
63) Bauer, S., et al., Neuroscience (2005) 130:75-90.
64) Herculano-Houzel, S. and
Data Sheet - CLLS1045
Bands q12-21.32. Genomics,
4, 362-366 (1989).
3. Schechter, A.L. et al., An Erb-b-related Gene
Encoding a 185,000 mw Tumour Antigen. Nature,
312, 513-516 (1984).
4. Coussens, L. et al., Tyrosine
Product Information Sheet-ehifi-ro
reactions of 20 μl final reaction volume. 11 814 362 001
Water, PCR Grade 25 ml, 25 x 1 ml 03 315 932 001
25 ml, 1 x 25 ml 03 315 959 001
100 ml, 4 x 25 ml 03
Product Information Sheet-ehifidntp-ro
reactions of 20 μl final reaction volume. 11 814 362 001
Water, PCR Grade 25 ml, 25 x 1 ml 03 315 932 001
25 ml, 1 x 25 ml 03 315 959 001
100 ml, 4 x 25 ml 03
Antibody SourceBook, Sixth Edition, DIST version
100 µl €362
Anti-Cannabinoid Receptor CB2 (1-32) Rabbit pAb IC human, rat 20955� 100 µl €362
Anti-Cannabinoid Receptor CB2 (1-33) Rabbit pAb IB, IC human; not mouse, not rat 209552 100 µl €362
Anti-Cannabinoid
MultiScreen Deep Well Solvinert Filter Plate: High throughput sample preparation for the quantitation of drug compounds in serum samples
serum samples using
liquid chromatography—tandem mass spectrometry. J. Chrom.B, 2002. 767, 353-362.
2 Žunic, G., et al., Optimization of a free separation of 30 free amino acids and peptides by capillary
Product Information Sheet-fhifi-ro
volume.
04 638 956 001
10 x 200 μl,
5,000 reactions of 20 μl final reaction volume.
11 814 362 001
PCR Nucleotide MixPLUS 2 x 100 μl, 200 PCR reactions in 50 μl 11
Product Information Sheet-taql-ro
11 814 362 001
GC-RICH PCR System 100 U, 50 reactions in a final volume of 50 μl 12 140 306 001
Water, PCR Grade 25 ml, 25 x 1 ml 03 315 932 001
25 ml, 1 x
Protein Tyrosine Phosphatases- Potential Roles in Disease
al., J. Virol., 69, 7823-7834 (1995).
79. Guan, K., et al., Nature, 350, 359-362 (1991).
80. Najarro, P., et al., J. Virol., 75, 3185-3196 (2001).
81. Bliska,, J.B., et al., J. Exp. Med., 176, 1625-1630
Product Information Sheet - CRISPRPL
30 minutes at
dark. Continue the digestion for 4 hours or longer if necessary with gentle shaking (30 rpm).
Filtrate released protoplasts through a 75 µm filter or screen pre‐washed with water and
equilibrated
Exploring Akt/mTOR Signaling Using the MILLIPLEX®MAP Akt/mTOR 11-plex Panel
Steele, V; Fay, J. Mol Cancer Ther. 2007, 6(8), 2139-48.
Wang, X; Proud, C. Physiology 2006, 21, 362-9.
Vignot, S; Faivre, S; Aguirre, D; Raymond, E. Annals of Oncology
2005, 16, 525-37.
Featured
Product Information Sheet-11480022001
reaction volume. 04 638 956 001
10 x 200 μl, 5,000 reactions of 20 μl final reaction volume. 11 814 362 001
PCR Nucleotide MixPLUS 2 x 100 μl, 200 PCR reactions in 50 μl 11 888 412 001
GC-RICH PCR
Protein Purification and Detection Tools
ed.
(Academic Press, New York) pp. 647–806.
4. Raines, R. T., McCormick, M., Van Oosbree, T. R., and Mierendorf, R. C. (2000) Meth.
Enzymol. 326, 362-376.
5. Keleman, B. R., Klink, T. A., Behlke
Pharmacopoeia Monograph Methods - HPLC and UHPLC methods for Regulated Drug Analysis
750
mAU
26
4
0 75
1.00
1000
1250
mAU
Peak
Purity Curve
200.0 225.0 250.0 275.0 300.0 325.0 350.0 nm
0
250
500
22
9
20
6
Application Notes Pharmacopoeia Monograph Methods
750
mAU
26
4
0 75
1.00
1000
1250
mAU
Peak
Purity Curve
200.0 225.0 250.0 275.0 300.0 325.0 350.0 nm
0
250
500
22
9
20
6
Pharmacopoeia Monograph Methods HPLC and UHPLC columns for Regulated Drug Analysis
750
mAU
26
4
0 75
1.00
1000
1250
mAU
Peak
Purity Curve
200.0 225.0 250.0 275.0 300.0 325.0 350.0 nm
0
250
500
22
9
20
6
Pharmacopoeia Monograph Methods
750
mAU
26
4
0 75
1.00
1000
1250
mAU
Peak
Purity Curve
200.0 225.0 250.0 275.0 300.0 325.0 350.0 nm
0
250
500
22
9
20
6
BRAND Katalog EN
II
4 4 4 4 4
4 4 4 4
4 4 4 4 4 4 4 4 4 4 4
4 4 4 4 4 4 4 4 4 4 4
4 4 4
Principles of Steam-In-Place
108 148 241 413 575 983
30 30 57 90 162 222 362 619 863 1474
3 20 26 50 79 141 194 316 541 754 1287
30 40 75 118 212 291 474 812 1131 1931
1/2